FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alejandro Majlis

Research Profile

Procedures

Antineoplastic Combined Chemotherapy Protocols

Chemicals & Drugs

Concepts & Ideas

Disorders

Physiology

Disease Progression

Anatomy

Philadelphia Chromosome

Co-author Network

Publications

TOP 3
Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Lucile Awad; Eric Van Cutsem
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Cindy Marabotti; Eric Van Cutsem
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alejandro Majlis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Lucile Awad; Eric Van Cutsem
Quality of life with docetaxel plus cisplatin and fluorouracil compared with cisplatin and fluorouracil from a phase III trial for advanced gastric or gastroesophageal adenocarcinoma: the V-325 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3210-6.
2007: Jaffer A Ajani; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Cindy Marabotti; Eric Van Cutsem
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3205-9.
2006: Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(31):4991-7.
2005: Jaffer A Ajani; Miguel Fodor; Sergei Tjulandin; Vladimir M Moiseyenko; Yee Chao; Sebastiao Cabral Filho; Alejandro Majlis; Sylvie Assadourian; Eric Van Cutsem
Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5660-7.
2005: Fernando Heredia; Marco Bravo; Mateo Pierotic; Alejandro Majlis; Leonardo Carmona
Neoadjuvant combined chemotherapy followed by external whole pelvic irradiation in two cases of primary extranodal non-Hodgkin's lymphoma of the uterine cervix.
Gynecologic oncology 2005;97(1):285-7.
1998: Jorge Cortes; Moshe Talpaz; Susan O'Brien; Mary Beth Rios; Alejandro Majlis; Michael Keating; Emil J Freireich; Andrew Lamb
Suppression of cytogenetic clonal evolution with interferon alfa therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3279-85.
1997: Alejandro Majlis; WC Pugh; Maria A Rodriguez; William F Benedict; Fernando Cabanillas
Mantle cell lymphoma: correlation of clinical outcome and biologic features with three histologic variants.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1664-71.
1996: Alejandro Majlis; Terry L Smith; Moshe Talpaz; Susan O'Brien; Mary Beth Rios; Hagop M Kantarjian
Significance of cytogenetic clonal evolution in chronic myelogenous leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):196-203.
1995: Andreas H Sarris; Alejandro Majlis; Meletios A Dimopoulos; Anas Younes; F Swann; Maria A Rodriguez; Peter McLaughlin; Fernando Cabanillas
Rising serum lactate dehydrogenase often caused by granulocyte-or Granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma.
Leukemia & lymphoma 1995;17(5-6):473-7.